Magellan Health (MGLN) Tops Q4 EPS Views; Guides FY15 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts MGLN Hot Sheet
Price: $94.99 --0%
Financial Fact:
Cost of goods sold: 509.67M
Today's EPS Names:
SICP, OMID, ELME, More
Financial Fact:
Cost of goods sold: 509.67M
Today's EPS Names:
SICP, OMID, ELME, More
Join SI Premium – FREE
Magellan Health (NASDAQ: MGLN) reported Q4 EPS of $1.32, $0.81 better than the analyst estimate of $0.51. Revenue for the quarter came in at $982.5 million versus the consensus estimate of $980.37 million.
Magellan Health sees FY2015 EPS of $3.33-$3.79, versus the consensus of $2.36.
For earnings history and earnings-related data on Magellan Health (MGLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Barclays Starts Life Time Group Holdings Inc (LTH) at Overweight
- Tata Motors (TMCV:IN) PT Raised to INR645 at UBS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
